Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beam Therapeutics, Inc.

25.95
-0.1600-0.61%
Volume:442.68K
Turnover:11.39M
Market Cap:2.10B
PE:-5.67
High:26.44
Open:25.31
Low:24.54
Close:26.11
Loading ...

Beam Therapeutics Appoints Sravan Emany as New CFO, Shares Up

Zacks
·
09 Dec 2024

Scotiabank Keeps Their Hold Rating on Beam Therapeutics (BEAM)

TIPRANKS
·
09 Dec 2024

Beam Therapeutics Advances BEAM-101 Therapy for Sickle Cell

TIPRANKS
·
09 Dec 2024

Analysts’ Top Healthcare Picks: Stoke Therapeutics (STOK), Beam Therapeutics (BEAM)

TIPRANKS
·
09 Dec 2024

William Blair Remains a Buy on Beam Therapeutics (BEAM)

TIPRANKS
·
09 Dec 2024

Beam Therapeutics Says Conditioning Platform Shows Potential in Sickle Cell Disease Treatment

MT Newswires Live
·
09 Dec 2024

Beam presents new NHP data demonstrating proof-of-concept for ESCAPE

TIPRANKS
·
09 Dec 2024

Beam Therapeutics announces new data from BEACON Phase 1/2 trial of BEAM-101

TIPRANKS
·
08 Dec 2024

BRIEF-Beam Therapeutics Says All 7 Patients Treated With Beam-101 Achieved Durable Increases In Fetal Hemoglobin, Reductions In Sickle Hemoglobin

Reuters
·
08 Dec 2024

Beam Therapeutics Announces New Data From Beacon Phase 1/2 Clinical Trial of Beam-101 in Sickle Cell Disease at American Society of Hematology (Ash) Annual Meeting

THOMSON REUTERS
·
08 Dec 2024

Beam Therapeutics: Initial Safety Profile Consistent With Busulfan Conditioning and Autologous Hematopoietic Stem Cell Transplantation

THOMSON REUTERS
·
08 Dec 2024

Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

GlobeNewswire
·
08 Dec 2024

Beam Therapeutics: All 7 Patients Treated With Beam-101 Achieved Durable Increases in Fetal Hemoglobin, Reductions in Sickle Hemoglobin

THOMSON REUTERS
·
08 Dec 2024

Aethir, Beam, and MetaStreet to Launch $40 Million AI Compute Initiative

BE[IN]CRYPTO
·
07 Dec 2024

Stock Market Rallies On: AI Software, Biotechs, Costco Coming Up

Blockhead
·
07 Dec 2024

Beam Therapeutics Names Sravan K. Emany as CFO

TIPRANKS
·
06 Dec 2024